Crossmark

Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis: part 1—results of the Canadian model in the Nordic cohort

Crossref DOI link: https://doi.org/10.1186/s13075-019-2060-2

Published Online: 2019-12-05

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Rypdal, Veronika http://orcid.org/0000-0003-3476-305X
Guzman, Jaime

Henrey, Andrew

Loughin, Thomas

Glerup, Mia

Arnstad, Ellen Dalen

Aalto, Kristiina

Rygg, Marite

Nielsen, Susan

Herlin, Troels

Fasth, Anders

Berntson, Lillemor

Rypdal, Martin

Nordal, Ellen
Funding

Funding for this research was provided by:

Helse Nord RHF
License Information

Text and Data Mining valid from 2019-12-01

Version of Record valid from 2019-12-05
More Information

Article History

Received: 25 July 2019

Accepted: 8 November 2019

First Online: 5 December 2019

Ethics approval and consent to participate

: Approval from medical research ethical committees and data protection authorities was granted according to the regulations of each participating country; in Norway, this was from the Regional Committee for Medical and Health Research Ethics NORD, number 53/96. Oral informed assent was obtained from all children. Written informed consent was obtained from parents of children aged < 16 years and from the children if aged ≥ 16 years of age.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below